The Pulmonary Vascular Research Institute
@PVRI
Followers
2K
Following
1K
Media
732
Statuses
2K
Pulmonary Vascular Research Institute (PVRI) is a global medical organisation focused on the improvement of care and awareness of pulmonary vascular diseases.
5 Tanner Street, London, SE13X
Joined May 2009
🚨 The wait is over — registration and abstract submissions are officially open for #PVRI2026 With the theme of Celebrating 20 Years of Progress & Innovation, join us in Dublin from 28 January – 1 February for world-class science, dynamic discussions, and impactful networking
0
3
7
Happening tomorrow! Join live at 16:00 BST, all welcome 👉
pvrinstitute.org
Webinar presentations: sotatercept – eligibility, dosing, results;Pulmonary vascular and right heart remodeling: what cardiac imaging and exercise tell us about Sotatercept;Genetic Background:...
📢 NEW PVRI Digital Webinar happening next week! 'Sotatercept: New Concepts and Clinical Use' is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' sessions, which takes place bi-monthly on the second Thursday at 16:00 GMT/BST. Presentations 🔹 Sotatercept –
0
0
0
Happening today 15:00 BST - Join to explore women's health and #PVD > Register here:
us02web.zoom.us
Welcome! You are invited to join a webinar: Women’s Health and Pulmonary Vascular Disease. After registering, you will receive a confirmation email about joining the webinar.
🚨 Women’s Health and Pulmonary Vascular Disease free webinar tomorrow! Join us 9 September 15:00 BST to explore women’s health and pulmonary vascular disease, hear from experts, and help shape the Task Force’s direction: 🔹 Background and PHANTOM trial results Steven Kawut,
0
1
2
🚨 Women’s Health and Pulmonary Vascular Disease free webinar tomorrow! Join us 9 September 15:00 BST to explore women’s health and pulmonary vascular disease, hear from experts, and help shape the Task Force’s direction: 🔹 Background and PHANTOM trial results Steven Kawut,
0
1
1
📢 NEW PVRI Digital Webinar happening next week! 'Sotatercept: New Concepts and Clinical Use' is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' sessions, which takes place bi-monthly on the second Thursday at 16:00 GMT/BST. Presentations 🔹 Sotatercept –
0
3
3
New publication: How Is Pulmonary Hypertension Characterised and Treated in Children With Trisomy 21? Observations From the TOPP Registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension) by Tilman Humpl Et al. Read the full research article➡️
0
1
1
The wait is over… the preliminary programme for #PVRI2026 Dublin is here! From sotatercept and translational science to AI, biomarkers, and global PH challenges, PVRI 2026 will showcase innovation shaping the next 20 years of pulmonary hypertension. Here’s a first look at
0
1
1
🎥 From Patient Voices to Action: Understanding the PH Global Survey - Webinar Recording Now Available On-Demand! Did you miss our live session on the Pulmonary Hypertension Global Patient Survey (PHGPS)? You can now catch up and watch the full discussion anytime. In this
0
1
5
New publication: Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational Model by Maria Niccum Et al. Read the full research article➡️ https://t.co/fD1taqmjsO
onlinelibrary.wiley.com
Pediatric pulmonary arterial hypertension (PAH) has a long asymptomatic period with progressive vascular loss. A recent computational model of simulated PAH in humans has demonstrated that up to 70%...
0
0
1
Happening tomorrow! Join live at 13:00 BST 👉 register for free
us02web.zoom.us
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom...
Next in our High Altitude Webinar Series: Hypoxia in Pulmonary Vascular Research – Altitude and Beyond🗻 📅 2 September 2025 | 13:00 BST 🎙️ A Matter of Degrees. The remarkable life of Mabel Purefoy FitzGerald, a pioneer in hypoxia acclimatization Expert speaker & moderators
0
1
1
Today, Hall Skaara the pleasure of co-presenting a webinar on the PH Global Patient Survey (PH GPS) with Wendy Gin-Sing (UK nurse). It was a great combo - patient + nursing perspectives - sharing findings from nearly 4,000 patients and carers worldwide. We also had 90+ live ⤵️
1
2
10
New publication: Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension by Laura Hardy Et al. Read the full research article➡️ https://t.co/OOuTdInzzG
onlinelibrary.wiley.com
Renal impairment is considered a contra-indication for lung (LTX) or combined heart-lung (HLTX) transplantation due to increased mortality. We hypothesized that renal impairment in pulmonary arteri...
0
0
1
Join at 11:00 BST today for a live webinar on the European findings from the #PHGPS survey. This session will discuss time to diagnosis, quality of life, access to care and the 10 Calls to Action https://t.co/GpilyVrvJE
@EuropePHA @EuropeanLung
0
0
1
New publication: Analysis of Clinical Characteristics of 54 Dead Pregnant Patients With Pulmonary Hypertension by Lishi Chen Et al. Read the full research article➡️ https://t.co/lniJv2mXwF
onlinelibrary.wiley.com
To analyze the clinical characteristics and potential pregnancy outcomes of deceased pregnant women with pulmonary hypertension, we conducted a retrospective analysis of clinical data from 54 cases...
0
0
1
⏰ Happening THIS Friday! Don’t miss our free webinar on the European findings from the PH Global Patient Survey (PHGPS). 📅 29 August | 11:00 BST | Online via Zoom Hear from Hall Skaara & Frances Varian on diagnosis, quality of life, access to care + the 10 Calls to Action. 🌍
📢 From Patient Voices to Action: Understanding the PH Global Survey - A Webinar for Patients and Carers on PHGPS European Findings 📅 Friday, 29 August | 🕚 11:00 BST | 💻 Online via Zoom We’re excited to invite you to a free, patient-focused webinar that unpacks key findings
0
2
3
From @PVRI Drug Discovery & Development Symposium 2025 — Dr. @SudarRajagopal (@DukeMedSchool) discusses the power & limits of imaging in proving disease-modifying effects in PH drug trials. Watch on Vumedi: https://t.co/4OCoBicPgS
#PulmonaryHypertension #PVRI #Vumedi
vumedi.com
Presented at PVRI's Drug Discovery & Development Symposium 2025, by Sudarshan Rajagopal, Duke University School of Medicine Imaging is essential for assessing right heart function and monitoring...
0
2
3
⏰ Happening tomorrow! Don’t miss this free session in the iPVD Virtual Symposium Series. Join Dr Prashant Bobhate as he explores ‘Pulmonary Hypertension in the Shadow of Infections: Challenges in Indian Practice’ — a vital discussion you won’t want to miss. 🗓️ 27 August 2025 ⏰
0
1
4
At @PVRI Congress 2025, Dr. Anna Hemnes (@VUMCDiscoveries) explores treating Group 1 PH in patients with comorbidities—balancing risks, benefits, and personalization. 📺 Watch now on #Vumedi: https://t.co/YGvOMbj4ik
#PVRI2025 #PAH #PulmonaryHypertension
vumedi.com
A case study of a 73-year-old woman with pulmonary arterial hypertension (PAH) reveals the complexities of treating PAH alongside multiple comorbidities. The discussion focuses on how these comorbi...
0
1
2
New publication: Global, Regional, and National Burden of Pulmonary Arterial Hypertension Among Women of Childbearing Age, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021 by Junjun Liu Et al. Read the full research article➡️ https://t.co/2JJSJLQQnr
onlinelibrary.wiley.com
Pulmonary arterial hypertension (PAH) is a common condition among women of childbearing age (WCBA) and is associated with adverse outcomes during pregnancy. However, there is currently a lack of...
0
0
4
Happening next week! Register for free & join the discussion 🎦
us02web.zoom.us
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom...
🌍 Upcoming webinar – free & open to all! Join us for the next session in the iPVD Virtual Symposium Series, where Prashant Bobhate will be discussing 'Pulmonary Hypertension in the Shadow of Infections: Challenges in Indian Practice'. 🗓️ 27 August 2025 ⏰ 3PM BST Moderated by
0
0
0